TS-0001 (15)

N/A

Report date: 2022/01/05 15:24:33

Base Information

Drug NameTS-0001 (15)
Drug Alias NameTS-0001 (15)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionV-set domain-containing T-cell activation inhibitor 1 inhibitors
TargetsV-set domain-containing T-cell activation inhibitor 1
Therapy Area/IndicationsEndometrial NeoplasmsOvarian NeoplasmsLiver Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Boan Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Boan Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsEndometrial NeoplasmsOvarian NeoplasmsLiver Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A